A study involving ten European countries, including Switzerland, has been launched to better understand monkeypox. It will follow people affected by the disease, record their symptoms and study their response to treatment.
This content was published on
2 minutes
Keystone-SDA/ts
Español
es
Suiza recluta pacientes para estudio de la viruela del mono
The Geneva University Hospitals (HUG) said it had recruited its first three patients.
The study builds on ongoing work in the Central African Republic to better characterise the disease in countries where recent spread has been reported. For the moment Switzerland is the first country to recruit patients for the study. The aim is to extend it to as many countries as possible.
“Thanks to this unprecedented international collaboration, we will be able to contribute to a better understanding of the disease and thus to adjust our response in the fight against it,” said Alexandra Calmy, head of the HIV/AIDS Unit at the HUG.
At least 500 patients are expected to be included in the study, she added. To date, ten countries have announced their participation: Switzerland, the UK, Belgium, France, Ireland, Italy, the Netherlands, Norway, Portugal and Spain.
Rarely fatal
Monkeypox is a relatively rare disease. It usually causes a painful rash but is rarely fatal. It was discovered in the late 1950s, with outbreaks occurring in communities in central and western Africa. The disease is now spreading to Europe.
More than 50 countries where monkeypox is not endemic have reported outbreaks of the viral disease as confirmed cases exceed 7,600. Switzerland had 140 confirmed cases as of July 8.
In Switzerland, as elsewhere in Europe, the population most affected by the disease comprises young men who are involved in “dense sexual networks” and in particular who report having gay sex, Calmy said.
More
More
South Africa confirms third monkeypox case in tourist from Switzerland
This content was published on
South Africa has confirmed a third case of monkeypox, in a 42-year-old male tourist from Switzerland.
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
This content was published on
The second case of monkeypox in Switzerland was detected in a person in Geneva, who was contaminated during a trip abroad.
Monkeypox medication not authorised in Switzerland
This content was published on
Tecovirimat and the latest smallpox vaccine, which help against monkeypox, are not available in Switzerland, the NZZ am Sonntag reports.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.